ARTICLE | Product Development
Actiq sales
September 22, 2003 7:00 AM UTC
Reformulated pain drugs can enjoy significant sales growth. Cephalon (CEPH) gained the rights to breakthrough cancer pain drug Actiq transmucosal fentanyl in October 2000 when it acquired Anesta in a ...